Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Rhone-Poulenc Rorer licenses Granocyte for additional countries

May 6, 1997

AGM-1470 may have potential for controlling fertility

May 6, 1997

Squalene synthase inhibitors reported by Takeda

May 6, 1997

Pfizer's CP-148623 lowers serum cholesterol in humans

May 6, 1997

BTS-67582 in diabetes

May 5, 1997

Hypolipidemic triterpenes claimed by Leo

May 5, 1997

Somatogen initiates phase II Optro trial for new indication

May 2, 1997

Ethical initiates U.S. pivotal trials of HRT combination patch

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...